News Hyperion DeFi, Inc.

Equities

HYPD

US30234E2037

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2025-07-15 pm EDT			5-day change	1st Jan Change
12.88 ^USD	+7.11%		+11.46%	+10.32%

Jul. 02	Eyenovia, Inc. will Change its Name to Hyperion DeFi, Inc	CI
Jul. 02	Eyenovia, Inc. will Change its Ticker to HYPD from EYEN	CI

Eyenovia, Inc. will Change its Name to Hyperion DeFi, Inc	Jul. 02	CI
Eyenovia, Inc. will Change its Ticker to HYPD from EYEN	Jul. 02	CI
Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi, Inc.	Jul. 02	AQ
Eyenovia Adds $10 Million in HYPE to its Treasury Holdings in Preparation for Strategic Onchain Engagement	Jun. 30	AQ
Eyenovia Announces Co-Branded Validator with Kinetiq	Jun. 26	AQ
Eyenovia, Inc. Announces Co-Branded Validator with Kinetiq	Jun. 25	CI
Eyenovia Announces Co-Branded Validator with Kinetiq	Jun. 25	AQ
Eyenovia, Inc. Announces Board and Executive Changes	Jun. 24	CI
Eyenovia Announces Closing of $50 Million Private Placement, Successful Accumulation of More Than One Million HYPE Tokens, and Update on its Optejet Development Program	Jun. 23	AQ
Eyenovia, Inc. announced that it has received $50 million in funding	Jun. 19	CI
Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group	Jun. 18	AQ
Eyenovia Announces Amendment of Debt Agreement with Avenue Capital Group	Jun. 18	CI
Top Premarket Decliners	Jun. 18	MT
Eyenovia Surges on Crypto Announcement	Jun. 17	DJ
Eyenovia Inc Announces $50 Million Private Placement In Public Equity	Jun. 17	RE
Eyenovia Shares Climb After $50 Million Financing to Create HYPE Crypto Reserve	Jun. 17	MT
Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy	Jun. 17	AQ
Eyenovia, Inc. announced that it expects to receive $50 million in funding	Jun. 16	CI
Eyenovia : Investor Presentation June 11 2025	Jun. 11	PU
Formosa Pharmaceuticals Ends Exclusive Licensing Deal With Eyenovia	Jun. 09	MT
Formosa Pharmaceuticals, Inc. Announces the Termination of Licensing Agreement with Eyenovia, Inc	Jun. 08	CI
Top Premarket Gainers	Jun. 06	MT
Eyenovia On May 30, Enters Third Amendment To Loan And Security Agreement - SEC Filing	Jun. 05	RE
Eyenovia, Inc. Enters into the Third Amendment to the Supplement to That Certain Loan and Security Agreement	Jun. 05	CI
Peraso Inc. (NASDAQ: PRSO): "The Convergence of Technical Momentum and Military Innovation" - More Stocks Inside	May. 21	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hyperion DeFi, Inc.

Equities

HYPD

US30234E2037

Pharmaceuticals

Filters